If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Curigliano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2020

Anaplastic Large-Cell Lymphoma
Breast Implants
Non-Hodgkin's Lymphoma
Therapeutics
Seroma

CDK4/6 inhibitors in breast cancer: one more step towards reduced mortality

Curigliano, G. & Loibl, S., Feb 2020, In : The Lancet Oncology. 21, 2, p. 191-192 2 p.

Research output: Contribution to journalComment/debate

Open Access
Ethics
Communication
Social Networking
Medical Oncology
Information Dissemination

Expression of tumor-associated antigens in breast cancer subtypes

Curigliano, G., Bagnardi, V., Ghioni, M., Louahed, J., Brichard, V., Lehmann, F. F., Marra, A., Trapani, D., Criscitiello, C. & Viale, G., Feb 2020, In : Breast. 49, p. 202-209 8 p.

Research output: Contribution to journalArticle

Open Access

Lucitanib for the treatment of HRþ/HER2- Metastatic breast cancer: Results from the multicohort phase II FINESSE study

Hui, R., Pearson, A., Cortes, J., Campbell, C., Poirot, C., Azim, H. A., Fumagalli, D., Lambertini, M., Daly, F., Arahmani, A., Perez-Garcia, J., Aftimos, P., Bedard, P. L., Xuereb, L., Scheepers, E. D., Vicente, M., Goulioti, T., Loibl, S., Loi, S., Pierrat, M. J. & 3 others, Turner, N. C., Andre, F. & Curigliano, G., Jan 15 2020, In : Clinical Cancer Research. 26, 2, p. 354-363 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Confidence Intervals
E-3810
Biomarkers